Trial NCT02392676

View at ClinicalTrials.gov 
Org. Study IDs: D0816C00009

Last trial update was posted on 2016-05-02

MeSH Interventions

Olaparib

MeSH Conditions

Carcinoma, Ovarian Epithelial Hypersensitivity Ovarian Neoplasms

Other Conditions

Platinum Sensitive Relapsed Ovarian Cancer

Stopping Reasons

Study is unlikely to be feasible given the evolving ovarian cancer landscape and alternative studies have the potential to meet future clinical demand.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID